Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,131 | 82 | 96.1% |
| Education | $87.00 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $479.91 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $332.98 | 11 | $0 (2024) |
| ABBVIE INC. | $289.49 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $166.30 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $145.05 | 7 | $0 (2024) |
| Seagen Inc. | $106.38 | 2 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $79.84 | 4 | $0 (2024) |
| PFIZER INC. | $61.45 | 3 | $0 (2024) |
| Incyte Corporation | $60.40 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $59.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,112 | 43 | ABBVIE INC. ($289.49) |
| 2023 | $672.43 | 28 | GlaxoSmithKline, LLC. ($285.39) |
| 2022 | $394.10 | 9 | Myriad Genetic Laboratories, Inc. ($219.27) |
| 2021 | $39.67 | 3 | PFIZER INC. ($14.65) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Oncology | ||||||
| 11/16/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $97.03 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $140.00 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Oncology | ||||||
| 09/25/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.68 | General |
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi, Nubeqa | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Oncology | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | IMJUDO (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $31.54 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 647 | 1,351 | $213,090 | $43,999 |
| 2022 | 7 | 355 | 582 | $135,874 | $28,155 |
| 2021 | 1 | 11 | 11 | $4,048 | $946.22 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 192 | $70,656 | $14,642 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 93 | $46,128 | $10,313 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 162 | $40,500 | $8,321 | 20.5% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2023 | 80 | 184 | $23,552 | $3,752 | 15.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 91 | 257 | $5,140 | $2,159 | 42.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 46 | 151 | $9,664 | $1,563 | 16.2% |
| 56820 | Exam of external female genitals using an endoscope | Office | 2023 | 16 | 23 | $8,740 | $1,513 | 17.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 45 | 150 | $5,400 | $1,142 | 21.1% |
| 83735 | Magnesium level | Office | 2023 | 11 | 30 | $870.00 | $197.10 | 22.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 12 | 21 | $714.00 | $133.14 | 18.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 43 | $688.00 | $94.60 | 13.8% |
| 84520 | Urea nitrogen level to assess kidney function, quantitative | Office | 2023 | 21 | 24 | $576.00 | $92.88 | 16.1% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 12 | 21 | $462.00 | $78.12 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 139 | $68,944 | $15,369 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 81 | $29,808 | $6,162 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 89 | $22,250 | $4,131 | 18.6% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2022 | 41 | 56 | $7,168 | $1,145 | 16.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 33 | 70 | $2,520 | $535.02 | 21.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 29 | 51 | $3,264 | $529.90 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 96 | $1,920 | $283.47 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 11 | $4,048 | $946.22 | 23.4% |
About Jill Smith, PA-C
Jill Smith, PA-C is a Medical healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1659853356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jill Smith, PA-C has received a total of $2,218 in payments from pharmaceutical and medical device companies, with $1,112 received in 2024. These payments were reported across 83 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,131).
As a Medicare-enrolled provider, Smith has provided services to 1,013 Medicare beneficiaries, totaling 1,944 services with total Medicare billing of $73,100. Data is available for 3 years (2021–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Tyler, TX
- Active Since 08/30/2018
- Last Updated 11/09/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1659853356
Products in Payments
- ZEJULA (Drug) $274.00
- MYRISK (Device) $260.64
- ELAHERE (Drug) $238.30
- LIBTAYO (Biological) $145.05
- myRisk (Device) $133.46
- IMJUDO (Biological) $86.72
- myChoice CDx (Device) $85.81
- MONJUVI (Drug) $60.40
- IMFINZI (Biological) $58.26
- JEMPERLI (Biological) $47.59
- TECVAYLI (Biological) $45.01
- KEYTRUDA (Biological) $42.16
- Onivyde (Drug) $41.99
- AYVAKIT (Drug) $38.44
- SOMATULINE DEPOT (Drug) $37.85
- VERZENIO (Drug) $36.56
- IMBRUVICA (Drug) $35.31
- ELIQUIS (Drug) $30.91
- IBRANCE (Drug) $30.54
- EPKINLY (Drug) $30.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Tyler
Mrs. Dawn O'neal, Pa-C, PA-C
Medical — Payments: $7,548
Olivia Snodgrass, Pa-C, PA-C
Medical — Payments: $7,119
William Mirabal, Pa-C, PA-C
Medical — Payments: $4,106
Johnson Mwangi, Pa-C, PA-C
Medical — Payments: $2,900
Ms. Shanequa Hambrick, Pa, PA
Medical — Payments: $2,765
Neal Burgess, Pa-C, PA-C
Medical — Payments: $2,750